SOLUSALT
LIVE

Serial Number

99441103

Owner

Bexson Biomedical, Inc.

Attorney

Aaron D. Hendelman

Filing Date

Oct 13, 2025

Add to watchlist:

No watchlists yet
View on USPTO

SOLUSALT Trademark

Serial Number: 99441103

SOLUSALT is a trademark filed by Bexson Biomedical, Inc. on October 13, 2025. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Bexson Biomedical, Inc. (4 trademarks)

856 Chelham Way
Santa Barbara, CA 93108

Entity Type: 03

Trademark Details

Filing Date

October 13, 2025

Registration Date

Not Registered

Goods & Services

chemicals, namely, cyclodextrins for industrial purposes; preparations derived from cyclodextrins, namely, chemicals for industrial purposes and active principles in the nature of active chemical ingredients, complexed by cyclodextrins, for use in the manufacture of pharmaceuticals and medicines; chemicals, namely, cyclodextrins and cyclodextrin derivatives for use in the chemical, plastics, paper, agricultural, horticultural, insulation, packaging, pharmaceutical, cosmetic, fragrance, textile, leather, healthcare, food and paint industries; active pharmaceutical ingredients, namely, salts for use in the manufacture of pharmaceuticals and medicines

research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; biomedical research and development services; scientific study and research in the fields of medicine, biomedical technology, and genetics

medical and scientific research in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; pharmaceutical research and development; drug discovery services; providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals

wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders

pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 17, 2026 GNRN
NON-FINAL ACTION E-MAILED
Mar 17, 2026 GNRT
NON-FINAL ACTION WRITTEN
Mar 17, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 11, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Oct 13, 2025 MAFR
NEW APPLICATION ENTERED
Oct 13, 2025 NWAP